Director, Supply Chain

BlueRock Therapeutics, a wholly-owned and independently operated subsidiary of Bayer AG, is a leading engineered cell therapy company pioneering a new generation of cellular medicines. Utilizing our proprietary CELL+GENETM platform, we direct cellular differentiation and genetically engineer cells to create transformative therapies for patients suffering from neurological and ophthalmological diseases.

Founded in 2016, BlueRock is at the forefront of the convergence of cell biology and genetic engineering. Our mission is to harness pluripotent stem cell technology and gene editing to deliver authentic, functional cell therapies that address the root causes of disease and offer hope to millions of patients worldwide.

What Are We Doing?

Our foundational science enables the generation and directed differentiation of universal pluripotent stem cells into authentic, functional cells for allogeneic cellular therapies.

We are passionate about realizing the promise of cell and gene therapy, shaping the future of regenerative medicine, and delivering new therapies to patients with limited or no treatment options.

Who is BlueRock?
BlueRock Therapeutics, a wholly owned and independently operated subsidiary of Bayer AG, is a leading engineered cell therapy company using its unique cell+gene platform to direct cellular differentiation and genetically engineer cells to create a new generation of cellular medicines that address large patient populations suffering from neurological, cardiovascular, and immunology diseases.

The convergence of cell biology and genetic engineering is creating fundamental new ways to impact disease. Founded in 2016 to capitalize on these technological breakthroughs, we are advancing our novel cell+gene platform to develop, manufacture, and deliver an entirely new generation of authentic and engineered cell therapies across two therapeutic areas: neurology and immunology.

What Are We Doing?
Our foundational science harnesses the ability to create and then direct the differentiation of universal pluripotent stem cells into authentic, functional cells that can be used as allogeneic cellular therapies to treat a broad array of diseases. We can also further engineer these cells, enabling them to produce enzymes, antibodies, and other proteins for additional therapeutic benefit.

We are passionate about delivering on the promise of cellular and gene therapy, shaping the future of cellular medicine, and delivering new therapies to millions of patients with treatment options.

We are seeking individuals who are collaborative, thrive in a fun and dynamic culture, and are steadfast in the commitment to advance cutting-edge cellular therapies to impact patients' lives.

Description Of Position
The Director, Supply Chain is responsible for leading BlueRock Therapeutics' end-to-end supply chain strategy and operations in support of research, process development, clinical manufacturing, and clinical trial execution. As a key member of the Cell Therapy Product Supply Operations organization, this role ensures the reliable, compliant, and scalable supply of critical materials, products, and services required to advance BlueRock's clinical-stage cell therapy portfolio.

The Director will establish and lead integrated planning, strategic sourcing, procurement, materials management, inventory control, and distribution capabilities across the organization. This individual will partner closely with Manufacturing, Technical Operations, MSAT, Process Development, Quality, Regulatory, Clinical Operations, and external suppliers to mitigate supply risk, improve operational performance, and enable successful delivery of clinical programs.

This leader will oversee teams responsible for procurement, planning, and materials management while building the processes, systems, and organizational capabilities necessary to support the business.

Responsibilities

Develop and lead an integrated supply planning process that aligns demand, manufacturing capacity, inventory, and sourcing strategies with CMC development plans and clinical program requirements.

Implement supply chain standards, metrics, and governance to improve forecasting accuracy, inventory performance, and operational execution.

Lead capacity planning and scenario modeling activities to support program prioritization, resource allocation, and business decision‐making.

Develop sourcing strategies for critical raw materials, consumables, testing services, and outsourced manufacturing activities to ensure continuity of supply and quality.

Build and maintain strategic partnerships with key suppliers to support clinical development timelines and long‐term business objectives.

Lead cross‐functional efforts to identify, assess, and mitigate supply and quality risks associated with critical materials and services.

Support supplier qualification